Three decrees published on Tuesday (27) in The Official Gazette of the Federation Expand treatment to Atopic dermatitis By the unified health system (they). Documents are based on the foundation of the general network of ointments of the skin – Tacrolimo and Mometsone van – as well as oral medicine to treat the disease – methotrexate.
In a statement, the Ministry of Health indicated that Van Tacrolimo and Mometsona can be used to treat people who cannot use corticosteroids or who have previously resistant treatments.
See more
“Expanding the scope of access to the topical tacrolimo for SOS patients is a relevant benefit, as it is a high -cost drug, their arrival was more restricted.”
According to the folder, methotrexate will be referred to in cases of acute atopic dermatitis, especially among patients who cannot use cyclosporine, a drug that has already been provided in the public network.
Understand
An unequal disease, atopic dermatitis is a genetic and chronic condition that is mainly characterized by severe itching and dry skin, which especially affects the areas of the body folds, such as the front of the elbows, behind the knees and neck.
“It is one of the most common forms of eczema, prevailing in childhood, although it may also arise in adolescence or adulthood,” the ministry said.
In young children, the face is also an area that is often affected by atopic dermatitis. “The disease can vary greatly from the patient to the patient, with different intensity and responses to treatments,” the volume added.
